Evidence map›Paper›PMID 38167838›Full record

ArticleNature communications2024

A distant global control region is essential for normal expression of anterior HOXA genes during mouse and human craniofacial development.

Andrea Wilderman, Eva D'haene, Machteld Baetens, Tara N Yankee, Emma Wentworth Winchester, Nicole Glidden, Ellen Roets, Jo Van Dorpe, Sandra Janssens, Danny E Miller and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Regulatory elements inGenetics in medicine open · 2024
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Andrea WildermanGraduate Program UConn Health, Farmington, CT, USA.ORCID 0000-0002-4832-9476
Eva D'haeneCenter for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.ORCID 0000-0002-5936-8294
Machteld BaetensCenter for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Tara N YankeeGraduate Program UConn Health, Farmington, CT, USA.
Emma Wentworth WinchesterGraduate Program UConn Health, Farmington, CT, USA.ORCID 0000-0003-2695-7938
Nicole GliddenDepartment of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT, USA.
Ellen RoetsDepartment of Obstetrics, Women's Clinic, Ghent University Hospital, Ghent, Belgium.
Jo Van DorpeDepartment of Pathology, Ghent University, Ghent University Hospital, Ghent, Belgium.ORCID 0000-0001-8175-2930
Sandra JanssensCenter for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.ORCID 0000-0001-7262-3715
Danny E MillerDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Washington, WA, USA.
Miranda GaleyDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Washington, WA, USA.ORCID 0000-0002-4721-7499
Kari M BrownDivision of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Rolf W StottmannSteve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.ORCID 0000-0003-4512-6806
Sarah VergultCenter for Medical Genetics, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.ORCID 0000-0002-0816-6262
K Nicole WeaverDivision of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Samantha A BrugmannDivision of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID 0000-0002-6860-6450
Timothy C CoxDepartment of Oral & Craniofacial Sciences, University of Missouri Kansas City, Kansas City, MO, USA.ORCID 0000-0001-8015-5528
Justin CotneyDepartment of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT, USA. cotney@uchc.edu.ORCID 0000-0001-8230-2157

Funding

Harnessing the therapeutic potential of neural crest cells by manipulating the primary ciliumR35DE027557 · NIDCR · CINCINNATI CHILDRENS HOSP MED CTR · PI BRUGMANN, SAMANTHA A · 2017 to 2024
$7.6M
Skeletal, Craniofacial and Oral Biology Training GrantT90DE021989 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MINA, MINA · 2011 to 2022
$4.5M
Unraveling mechanisms of genome regulation to understand and improvehuman healthR35GM119465 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COTNEY, JUSTIN LEE · 2016 to 2025
$3.9M
Skeletal, Craniofacial and Oral Biology Training GrantT90DE033006 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI FRANK C NICHOLS · 2023 to 2026
$2.0M
Long-read DNA and RNA sequencing to identify disease-causing genetic variation and streamline testingDP5OD033357 · OD · UNIVERSITY OF WASHINGTON · PI MILLER, DANNY ERWIN · 2022 to 2025
$1.9M
Functional characterization of craniofacial enhancers at single cell and single base pair resolutionR01DE028945 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COTNEY, JUSTIN LEE · 2019 to 2023
$1.9M
Integrated multi-omics analyses of early mammalian craniofacial developmentR03DE028588 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI COTNEY, JUSTIN LEE · 2020 to 2021
$328k
NIDCR NIH HHS R01 DE028945NIDCR NIH HHS R03 DE028588NIDCR NIH HHS R35 DE027557NIDCR NIH HHS T90 DE021989NIDCR NIH HHS T90 DE033006NIGMS NIH HHS R35 GM119465NIH HHS DP5 OD033357Wellcome Trust
6 · The paper itself

Abstract

Craniofacial abnormalities account for approximately one third of birth defects. The regulatory programs that build the face require precisely controlled spatiotemporal gene expression, achieved through tissue-specific enhancers. Clusters of coactivated enhancers and their target genes, known as superenhancers, are important in determining cell identity but have been largely unexplored in development. In this study we identified superenhancer regions unique to human embryonic craniofacial tissue. To demonstrate the importance of such regions in craniofacial development and disease, we focused on an ~600 kb noncoding region located between NPVF and NFE2L3. We identified long range interactions with this region in both human and mouse embryonic craniofacial tissue with the anterior portion of the HOXA gene cluster. Mice lacking this superenhancer exhibit perinatal lethality, and present with highly penetrant skull defects and orofacial clefts phenocopying Hoxa2-/- mice. Moreover, we identified two cases of de novo copy number changes of the superenhancer in humans both with severe craniofacial abnormalities. This evidence suggests we have identified a critical noncoding locus control region that specifically regulates anterior HOXA genes and copy number changes are pathogenic in human patients.

Indexed as

Cleft LipCleft PalateAnimalsBasic-Leucine Zipper Transcription FactorsFemaleGene Expression Regulation, DevelopmentalGenes, HomeoboxHumansMicePregnancyBasic-Leucine Zipper Transcription FactorsNFE2L3 protein, human

Identifiers

PMID38167838
PMCPMC10762089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.